Common Contracts
8 similar Underwriting Agreement contracts by PRA Health Sciences, Inc., Gulfport Energy Corp, Celsus Therapeutics Plc., others
7,500,000 Shares of Common Stock PRA Health Sciences, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • November 16th, 2016 • PRA Health Sciences, Inc. • Services-commercial physical & biological research • New York
5,000,000 Shares of Common Stock PRA Health Sciences, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • May 6th, 2016 • PRA Health Sciences, Inc. • Services-commercial physical & biological research • New York
Introductory. Each of (i) KKR PRA Investors L.P. (the “KKR Selling Stockholder”) and (ii) Linda Baddour (the “Management Selling Stockholder” and together with the KKR Selling Stockholder, the “Selling Stockholders”), as a stockholder of PRA Health Sciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Wells Fargo Securities, LLC (the “Underwriter”) the number of shares of the Company’s common stock, par value $0.01 per share (the “Shares”) set forth next to such Selling Stockholder’s name on Schedule B hereto. The aggregate 5,000,000 Shares to be sold by the Selling Stockholders are called the “Offered Shares.”
5,000,000 Shares of Common Stock PRA Health Sciences, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • March 8th, 2016 • PRA Health Sciences, Inc. • Services-commercial physical & biological research • New York
Introductory. Each of (i) KKR PRA Investors L.P. (the “KKR Selling Stockholder”), (ii) Colin Shannon and (iii) Linda Baddour (together with Colin Shannon, the “Management Selling Stockholders” and together with Linda Baddour and the KKR Selling Stockholder, the “Selling Stockholders”), as a stockholder of PRA Health Sciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Credit Suisse Securities (USA) LLC (the “Underwriter”) the number of shares of the Company’s common stock, par value $0.01 per share (the “Shares”) set forth next to such Selling Stockholder’s name on Schedule B hereto. The aggregate 5,000,000 Shares to be sold by the Selling Stockholders are called the “Offered Shares.”
Celsus Therapeutics PLC [_________] American Depositary Shares Representing [________] Ordinary Shares (Nominal Value ₤0.01 Per Ordinary Share) UNDERWRITING AGREEMENTUnderwriting Agreement • January 28th, 2014 • Celsus Therapeutics Plc. • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • June 22nd, 2012 • Urologix Inc • Electromedical & electrotherapeutic apparatus • Minnesota
Mindray Medical International Limited 4,000,000 American Depositary Shares Representing 4,000,000 Class A Ordinary Shares (Par Value HK$0.001 Per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • March 8th, 2010 • Mindray Medical International LTD • Surgical & medical instruments & apparatus
The Offered ADSs are to be issued pursuant to a deposit agreement (the “Deposit Agreement”), dated as of September 29, 2006, among the Company, The Bank of New York Mellon, as depositary (the “Depositary”), and holders from time to time of the American Depositary Receipts (the “ADRs”) issued by the Depositary and evidencing the Offered ADSs. Each ADS will initially represent the right to receive one Ordinary Share deposited pursuant to the Deposit Agreement.
Gulfport Energy Corporation Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • May 18th, 2007 • Gulfport Energy Corp • Crude petroleum & natural gas • New York
Gulfport Energy Corporation Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 1st, 2007 • Gulfport Energy Corp • Crude petroleum & natural gas • New York
